Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Frontiers in Medicine|November 8, 2021
Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological StrategiesWeiyi Qu, Tengfei Ma, Jingjing Cai, et al.Plos One|August 29, 2018
Selective ablation of the ligament of Marshall reduces ischemia and reperfusion-induced ventricular arrhythmiasRuisong Ma, Zhiliang Qin, Xiaomei Yu, et al.Pacing and Clinical Electrophysiology : PACE|November 15, 2018
Selective ablation of atrial ganglionated plexus attenuates vasovagal reflex in a canine modelXiaoying Wang, Da Luo, Shan Liu, et al.JACC. Clinical Electrophysiology|April 22, 2023
Pulmonary Artery Denervation Inhibits Left Stellate Ganglion Stimulation-Induced Ventricular Arrhythmias Originating From the RVOTMeng Zheng, Ke-Qiong Deng, Xiaoying Wang, et al.Journal of Lipid Research|January 31, 2024
Histone demethylase KDM1A promotes hepatic steatosis and inflammation by increasing chromatin accessibility in NAFLDZifeng Yang, Siyao Zhang, Xiang Liu, et al.Journal of Lipid Research|May 31, 2025
Hepatoprotective drug screening identifies daclatasvir, a promising therapeutic candidate for MASLD by targeting PLIN2Rui Shu, Song Tian, Weiyi Qu, et al.Frontiers in Endocrinology|May 27, 2022
Profound Perturbation in the Metabolome of a Canine Obesity and Metabolic Disorder ModelWeiyi Qu, Ze Chen, Xing Hu, et al.Gut|November 27, 2025
Discovery of a carboxyl fullerene derivative as a new lipid droplet regulator inhibiting MASLDToujun Zou, Juan Wan, Rufang Liao, et al.The Journal of Clinical Investigation|September 2, 2025
Integrated screening identifies GPR31 as a key driver and druggable target for metabolic dysfunction-associated steatohepatitisXiao-Jing Zhang, Jiajun Fu, Xu Cheng, et al.Science Translational Medicine|February 14, 2024
Multispecies transcriptomics identifies SIKE as a MAPK repressor that prevents NASH progressionLan Bai, Weiyi Qu, Xu Cheng, et al.Pageof 1